SHR-7787 Injection

DRUG3 trials

Sponsors

Shanghai Hengrui Pharmaceutical Co., Ltd.

Conditions

Advanced Solid TumorsLimited-stage Small-cell Lung CancerMalignant Solid Tumors

Phase 1

A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

RecruitingNCT06605222

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2024-10-04End: 2026-11-30Target: 201Updated: 2024-10-18

Phase 2

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

RecruitingNCT07268040

Shanghai Hengrui Pharmaceutical Co., Ltd.Malignant Solid Tumors

Start: 2025-12-23End: 2028-12-31Target: 400Updated: 2026-01-12

A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC

Not yet recruitingNCT07798947

Shanghai Hengrui Pharmaceutical Co., Ltd.Limited-stage Small-cell Lung Cancer

Start: 2026-09-01End: 2028-12-01Target: 120Updated: 2026-09-02